Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace

After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study. Source: BioSpace

Spark won approval on Dec. 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65. Source: BioSpace

Biotech and pharma execs Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx. Source: BioSpace

The company struck the cash-and-share deals to boost its presence in Europe. Source: BioSpace

This acquisition strategy is part of its two-pronged approach to growth, along with internal R&D. Source: BioSpace

Could Cara be the answer for investors itching to make $1 million? Source: BioSpace

But for now, the world’s biggest healthcare company isn’t providing many details on how it may use the extra money from lower tax rates. Source: BioSpace

Significant risk remains for companies that cannot move quickly enough to positively impact R&D productivity and for those that encounter challenges in accessing technology and expertise that likely lie outside…

Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace